Techh.info/biomedtechnology hourly

Cancer

headlines texts
22.08.2019
01:41 Drugs.comDrug Offers Hope Against a Tough-to-Treat Blood Cancer

WEDNESDAY, Aug. 21, 2019 -- Patients with a form of blood cancer known as multiple myeloma who haven't responded to other therapies might have a new weapon against the disease, researchers say. A drug called selinexor appeared to help patients with...

Скрыть анонс
21.08.2019
21:53 Reuters.com HealthWith cancer risk timeline, middle-aged women recognize need for cervix screening

(Reuters Health) - When middle-aged women realize their cervical cancer risk from HPV lasts decades, more of them decide to get screened for this cancer than when they only know HPV has a role in cancer, without an explicit timeline, a small study found.

Скрыть анонс
20:42 ScienceDaily.comResearchers convert pro-tumor macrophages into cancer killers

Researchers identified a new therapeutic approach in mouse models that halts drug resistance and cancer progression by using an antibody that induces the immune system via macrophages to seek and kill cancer cells.

Скрыть анонс
20:15 Drugs.comMore Antibiotics, Higher Odds for Colon Cancer?

WEDNESDAY, Aug. 21, 2019 -- Taking certain antibiotics -- especially multiple times or for long courses -- may put you at risk for colon cancer, a large new study suggests. The researchers found that as people's antibiotic use increased, their odds...

Скрыть анонс
18:58 Yahoo ScienceNuCana Stops Patient Enrollment in Pancreatic Cancer Study

NuCana (NCNA) suspends patient enrollment in the phase III study on Acelarin, currently evaluated for treating patients with metastatic pancreatic cancer, who were unfit for combination chemotherapy.

Скрыть анонс
18:45 Phys.orgChemical imaging used to aid diagnosis of colon cancer

Researchers have developed a method of chemical imaging which identifies colon cancer more accurately and efficiently than traditional methods.

Скрыть анонс
18:36 Yahoo ScienceAstraZeneca s Imfinzi Fails in Stage IV Lung Cancer Study

AstraZeneca's (AZN) Imfinzi fails to improve overall survival in a study for previously treated stage IV non-small cell lung cancer (NSCLC) patients.

Скрыть анонс
17:04 CancerNetwork.comTimelines Matter in the Treatment of Breast Cancer

Researchers looked at the time between receiving a diagnosis and beginning chemotherapy to see if a delay in treatment impacted the overall survival in  patients with breast cancer.

Скрыть анонс
16:28 Phys.org'Yin and yang' enzymes evolved over billions of years to protect against cancer

Researchers at the University of Dundee have made an important discovery about two enzymes that have evolved over billions of years to control many different bodily functions, including playing a critical role in preventing cancer.

Скрыть анонс
15:09 Reuters.com HealthAstraZeneca Imfinzi combination fails advanced lung cancer study

A combination of AstraZeneca's lung cancer drug Imfinzi and an experimental treatment failed to extend the lives of patients with advanced non-small cell lung cancer (NSCLC) and high levels of gene mutations, the drugmaker said on Wednesday.

Скрыть анонс
14:47 Phys.orgResearchers make potential breakthrough in cancer drug development

A Victoria University of Wellington research team has developed an exciting new lead in the search for cancer treatments, creating alternative versions in the laboratory of a rare natural compound that targets some types of cancer.

Скрыть анонс
12:15 Zdnet.comCancer research organizations are now the focus of Chinese hacking groups

One way to speed up research? Steal it.

Скрыть анонс
11:02 News-Medical.NetSociodemographic factors predict discriminatory oral cancer screening practices

Oral cancer accounts for 2 percent of reported malignancies and 1.2 percent of cancer-related deaths in the United States.

Скрыть анонс
11:02 News-Medical.NetDrug that treat human breast cancer might also work for canine lung cancer

Despite those velvet paintings of poker-playing dogs smoking pipes, cigars and cigarettes, our canine friends really don't use tobacco. But like many humans who have never smoked, dogs still get lung cancer.

Скрыть анонс
11:02 News-Medical.NetFDA clears its IND for new immunotherapeutic for treating prostate cancer

Calibr, the drug development division of Scripps Research, announced today that the U.S. Food and Drug Administration has cleared its investigational new drug application for CCW702, a novel immunotherapeutic for the treatment of patients with metastatic castration-resistant prostate cancer.

Скрыть анонс
10:20 Yahoo ScienceAstraZeneca s Imfinzi combination fails advanced lung cancer study

The clinical trial, called NEPTUNE, was testing Imfinzi along with FDA-approved tremelimumab and comparing the combination to platinum-based chemotherapy to treat patients whose cancer had spread to other parts of the body. London-listed AstraZeneca said though the trial involved a wide range of patients, the primary group being tested had high levels of mutations in their DNA.

Скрыть анонс
10:18 Reuters.com HealthAstraZeneca's Imfinzi combination fails advanced lung cancer study

AstraZeneca said on Wednesday a combination treatment including its lung cancer drug Imfinzi failed to extend the lives of patients with advanced non-small cell lung cancer (NSCLC) and high levels of gene mutations.

Скрыть анонс
09:56 Reuters.com HealthAstraZeneca's Imfinzi misses main goal of advanced lung cancer study

London-listed drugmaker AstraZeneca Plc said on Wednesday its immunotherapy treatment Imfinzi did not meet the main goal of a late-stage study for advanced non-small cell lung cancer.

Скрыть анонс
09:31 News-Medical.NetCancer survivors could be at greater risk of cardiovascular diseases

Over the last few decades, medical progress has led to the survival of many more people with cancer. However, a new study published in The Lancet shows that this cohort has a higher risk of cardiovascular disease (CVD) than controls without cancer, due to a number of reasons.

Скрыть анонс
06:14 News-Medical.NetNew insight into the immune system may help doctors to better fight cancer

Your immune system's natural killer cells recognize and attack two major kinds of danger - cells infected by viruses and cells affected by cancer.

Скрыть анонс
04:07 Yahoo ScienceNew study links antibiotic use with a higher risk of bowel cancer

New research has found that antibiotic use is linked to an increased risk of bowel (colon) cancer, but a lower risk of rectal cancer, suggesting that, to some extent, the risk of cancer may depend on the type and class of antibiotics prescribed. Carried out by researchers at Johns Hopkins University School of Medicine, USA along with the University of East Anglia Norwich Medical School and Norfolk and Norwich University Hospital NHS Trust, UK, the new study set out to investigate how the strong and long-lasting impact of antibiotics on the gut microbiome, which is the balance of helpful and harmful bacteria in the gut, could affect bowel and rectal cancer risk. To do so, the researchers looked at the medical records of 19,276 patients diagnosed with bowel cancer and 9,254 patients diagnosed with rectal cancers who

Скрыть анонс
03:53 MedicalNewsToday.comMedical News Today: What to know about HER2-negative breast cancer

There are two main types of HER2-negative breast cancer: hormone receptor-positive and triple-negative. Many treatments exist, and prognosis varies. Learn more here.

Скрыть анонс
03:53 MedicalNewsToday.comMedical News Today: Cancer more common in females with severe sleep apnea

A new study of 20,000 adults with sleep apnea suggests that the risk of cancer could be 2–3 times higher among females with a severe form of the condition.

Скрыть анонс
03:39 ScienceDaily.comAntibiotic use linked to heightened bowel cancer risk

Antibiotic use (pills/capsules) is linked to a heightened risk of bowel (colon) cancer, but a lower risk of rectal cancer, and depends, to some extent, on the type and class of drug prescribed, suggests new research.

Скрыть анонс
20.08.2019
23:00 ScienceDaily.comTreating dogs with human breast cancer drug

Like many women who develop a particular type of breast cancer, the same gene -- HER2 -- also appears to be the cause of lung cancer in many dogs. Researchers found that neratinib -- a drug that has successfully been used to battle human breast cancer -- might also work for many of the nearly 40,000 dogs in the US that annually develop the most common type of canine lung cancer, known as CPAC.

Скрыть анонс
21:30 ScienceDaily.comNovel combination of drugs may overcome drug-resistant cancer cells

A new study suggests that a combination of three drugs, including a new class of glucose-6-phosphate dehydrogenase inhibitors, could overcome cross-therapy resistance.

Скрыть анонс
20:52 Drugs.comU.S. Task Force Updates Breast Cancer Gene Testing Recommendations

TUESDAY, Aug. 20, 2019 -- Mutations in two genes -- BRCA1 and BRCA2 -- are known to significantly increase the risk of breast cancer, but experts have long debated which women should be tested for them. New recommendations from the U.S. Preventive...

Скрыть анонс
19:58 Yahoo ScienceStudy on cannabis chemical as a treatment for pancreatic cancer may have major impact, Harvard researcher says

Scientists from Harvard University's Dana-Farber Cancer Institute have found evidence that a chemical derived from cannabis may be capable of extending the life expectancy for pancreatic cancer.

Скрыть анонс
19:56 Reuters.com HealthExpert panel updates advice on BRCA cancer gene screening

(Reuters Health) - Mutations in the BRCA1 and BRCA2 genes are associated with increased risks for breast, ovarian, and other cancers, but only certain women stand to benefit from genetic testing, according to updated recommendations from the U.S. Preventive Services Task Force (USPSTF).

Скрыть анонс
18:31 ScienceDaily.comA new path to cancer therapy: developing simultaneous multiplexed gene editing technology

Scientists have developed a new gene editing system that could be used for anticancer immunotherapy through the simultaneous suppression of proteins that interfere with the immune system expressed on the surface of lymphoma cells and activation of cytotoxic T lymphocyte.

Скрыть анонс
17:05 Phys.orgA new path to cancer therapy: Developing simultaneous multiplexed gene editing technology

Dr. Mihue Jang and her group at the Center for Theragnosis of the Korea Institute of Science and Technology (KIST, President Byung-gwon Lee) announced that they have developed a new gene editing system that could be used for anticancer immunotherapy through the simultaneous suppression of proteins that interfere with the immune system expressed on the surface of lymphoma cells and activation of cytotoxic T lymphocyte, based on the results of joint research conducted with Prof. Seokmann Hong and his group at Sejong University (President, Deg-hyo Bae).

Скрыть анонс
15:33 BBC HealthKelliyah was diagnosed with ovarian cancer when she was 14 years old

The most deadly gynaecological disease, less than 2% of cases affect women under 20.

Скрыть анонс
15:12 Nanowerk.comNano-vaccine offers hope for effective skin cancer treatment

Researchers have developed and tested a novel approach for tackling melanoma.

Скрыть анонс
14:13 BBC Health'Why me? I had ovarian cancer at 14'

Kelliyah thought she was simply putting on weight - and was shocked to find her condition was much more serious.

Скрыть анонс
11:20 Technology.orgTreat cancer with cold plasma? Purdue aerospace engineer helps bring first clinical trial

Purdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel,

Скрыть анонс
10:23 GizmagFDA approves clinical trial of cold plasma "scalpel" for cancer treatment


Cancer is a crafty foe, not least because traces often remain after surgery and can trigger a relapse later on. Now a new technology to fight those dangerous leftovers – a cold atmospheric plasma system – has been approved for human clinical trials by the US Food and Drug Administration (FDA).
.. Continue Reading FDA approves clinical trial of cold plasma "scalpel" for cancer treatment Category: Medical Tags: Cancer FDA Plasma Purdue University Surgery Tumor

Скрыть анонс
09:24 News-Medical.NetDacomitinib treatment for lung cancer increases overall survival but has more side effects

Since its approval in April 2019, dacomitinib has been available for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor activating mutations.

Скрыть анонс
06:35 News-Medical.NetStudy uncovers potential new treatment approach for lung cancer

Lung cancer is the second most common cancer found in both men and women. It is estimated there will be roughly 228,000 new lung cancer cases this year, and nearly 30% of those patients will have mutations in the KRAS pathway.

Скрыть анонс
05:38 News-Medical.NetStudy shows synergistic effects of drugs that inhibit cell division in pancreatic cancer

Pancreatic cancer is one of the deadliest cancers, with patients surviving on average less than a year once the disease has spread.

Скрыть анонс
03:38 News-Medical.NetHCI unveils new mobile outreach vehicle to offer education, cancer screening services

Today Huntsman Cancer Institute at the University of Utah unveiled the Cancer Screening and Education bus.

Скрыть анонс
19.08.2019
22:29 ScienceDaily.comPossible new treatment strategy for lung cancer

It is estimated there will be roughly 228,000 new lung cancer cases this year, and nearly 30% of those patients will have mutations in the KRAS pathway. This type of mutation makes the cancer more aggressive and difficult to treat. Researchers are hoping to change that. They have now discovered a new treatment approach that may help this group of patients.

Скрыть анонс
20:53 CancerNetwork.comCan Physical Activity Delay Progression in Metastatic Colorectal Cancer?

A new study looked at the physical activity among patients with metastatic colorectal cancer to see if it affected disease progression and overall survival.

Скрыть анонс
19:10 CancerNetwork.comQuestions Remain About the Role of Transoral Surgery for Oropharyngeal Cancer

Researchers compared the swallowing-related quality-of-life scores of patients with oropharyngeal squamous cell carcinoma who received radiotherapy and patients who received transoral robotic surgery with neck dissection.

Скрыть анонс
18:52 ScienceDaily.comTargeting cell division in pancreatic cancer

Study provides new evidence of synergistic effects of drugs that inhibit cell division and support for further clinical trials.

Скрыть анонс
14:51 NewScientist.ComGenetic studies hint alcohol isn’t linked to breast cancer after all

Genetic studies rebut current warnings from health officials that alcohol causes breast tumours, and that even light drinking causes throat cancer

Скрыть анонс
18.08.2019
18:45 News-Medical.NetProtein governing platinum-resistant ovarian cancer identified

The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center.

Скрыть анонс
18:40 ScienceDaily.comIdentification of genes responsible for sex-related differences in cancer aggressiveness

An understanding of the molecular basis of differences in the incidence and survival of cancer between men and women may allow the discovery of specific and more effective treatments. The study compares the brain tumours of male and female flies at the molecular level and identifies proteins responsible for the different degree of aggressiveness.

Скрыть анонс
13:46 StemCellsPortal.comlEngineered Stem Cells for Targeted Cancer Therapy

Multiple stem cell types exhibit inherent cancer tropism, while engineered stem cells have been used as therapeutic agents to specifically target cancer cells. More recently, stem cells engineering has been employed to target multiple surface‐receptors on tumor cells, as well as endothelial and immune cells of the tumor microenvironment. In a new review published in STEM CELLS, researchers led by Sanam L. Kavari and Khalid Shah (Harvard Medical School, Boston, Massachusetts, USA) discuss the rationales and strategies of developing multiple receptor-targeted stem cells, their mechanisms of action, and the promises and challenges that they hold as cancer therapeutics.


Скрыть анонс
10:03 News-Medical.NetResearch finds lack of racial diversity in clinical trials for cancer drugs

New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs.

Скрыть анонс
03:50 MedicalNewsToday.comMedical News Today: The power of electromagnetic energy on breast cancer cells

Electromagnetic energy could be used to halt the movement of breast cancer cells, reducing metastatic cases. New research explains how.

Скрыть анонс
17.08.2019
09:48 NewScientist.ComGenetic studies suggest alcohol isn’t linked to breast cancer afterall

Genetic studies rebut current warnings from health officials that alcohol causes breast tumours, and that even light drinking causes throat cancer

Скрыть анонс
03:50 MedicalNewsToday.comMedical News Today: Simple dietary changes may reduce cancer risk, increase lifespan

The health benefits of fruit and vegetables are partly due to flavonoids. A new study concludes that consuming more flavonoids each day may extend life.

Скрыть анонс
01:41 CancerNetwork.comIncreased Survival in Metastatic Pancreatic Cancer

Скрыть анонс
00:01 Reuters.com HealthRoche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi

Roche Holding AG has priced its personalized cancer treatment, Rozlytrek, at about $17,050 per month, nearly half of the monthly price of a rival drug from Bayer AG and Eli Lilly and Co that was approved last year.

Скрыть анонс
16.08.2019
18:54 BBC HealthClatterbridge Cancer Centre 'may lose proton beam therapy'

Aging proton beam technology at Clatterbridge Cancer Centre may not be replaced, health bosses warn.

Скрыть анонс
18:46 Reuters.com HealthRoche personalized cancer treatment to cost about $204,560 a year

Roche Holding AG has priced at about $204,560 a year its personalized cancer treatment, Rozlytrek, that targets tumors with specific genetic mutations, the Swiss drugmaker said.

Скрыть анонс
18:12 Reuters.com HealthNordic walking may benefit breast cancer patients

(Reuters Health) - Nordic walking, an aerobic activity performed with walking poles similar to ski poles, may benefit patients with breast cancer, according to a review of existing research.

Скрыть анонс
18:12 Reuters.com HealthRoche prices personalized cancer treatment at about $204,560 annually

Roche Holding AG priced at about $204,560 a year its personalized cancer treatment, Rozlytrek, which targets tumors with specific genetic mutations, the Swiss drugmaker said.

Скрыть анонс
17:15 Reuters.com HealthFDA approves Celgene's bone marrow cancer treatment

The U.S. Food and Drug Administration said on Friday it had approved Celgene Corp's treatment, Inrebic, for certain forms of bone marrow cancer.

Скрыть анонс
16:52 Nanowerk.comFluorescent carbon dots could make cancer treatment safer and more effective

Researchers develop new technique with carbon nanoparticles to make photodynamic therapy safer, cheaper and more effective.

Скрыть анонс
16:06 Phys.orgTiny fluorescent carbon dots could make cancer treatment safer and more effective

A pioneering new technique that could make light-based cancer treatment more effective and safer for patients, while reducing its cost, has been developed by researchers from the University of Sheffield.

Скрыть анонс
14:10 BBC HealthWomen take legal action over breast implant cancer link

Twenty UK women are taking legal action over a rare type of breast implant-related cancer.

Скрыть анонс
13:35 FightAging.OrgSenescent Cells Increase Risk of Colon Cancer via Secretion of GDF15

Cells that enter a senescent state have many purposes in the body. They are involved in both wound healing and cancer suppression, for example. Senescence also serves to remove somatic cells that reach the Hayflick limit on replication. Senescent cells secrete a potent mix of signals to rouse the immune system and encourage local tissue regrowth and remodeling. This is all useful in the short term, where senescent cells accomplish the immediate task at hand and then self-destruct or are destroyed by immune cells. Wounds are healed, and potentially cancerous cells destroyed. Yet cellular senescence is a cause of aging. The problems arise due to the tiny fraction of senescent cells that evade destruction and linger in the body in increasing numbers with advancing age. […]

Скрыть анонс
12:37 News-Medical.NetTargeted pancreatic cancer drug shows promise in clinical trials

Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.

Скрыть анонс
10:53 Technology.orgBalance of “Stop” and “Go” Signaling Could Be Key to Cancer Immunotherapy Response

A crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted

Скрыть анонс
15.08.2019
23:19 Reuters.com HealthRoche's personalized cancer treatment wins FDA approval

The U.S. Food and Drug Administration approved Roche Holding AG's personalized cancer treatment, the agency said on Thursday.

Скрыть анонс
20:11 ScienceDaily.comMutations linked to familial pancreatic cancer

A new study finds genetic mutations associated with hereditary forms of pancreatic cancer and mechanism by which these mutations may contribute to the development of tumors.

Скрыть анонс
19:32 CancerNetwork.comDo Early Changes to Dosing of T-DM1 Affect Outcomes in HER2-Positive Breast Cancer?

A new analysis looked at how dose interruptions or reductions of ado-trastuzumab emtansine in the treatment of advanced HER2-positive breast cancer impacted long-term survival outcomes.

Скрыть анонс
18:23 CancerNetwork.comDr. Kelly Hunt on the Role of Surgery in Metastatic Breast Cancer

Cancer Network spoke with Kelly Hunt, MD, professor and chair of the department of breast surgical oncology, at the MD Anderson Cancer Center in Houston, about the role of surgery in metastatic breast cancer.

Скрыть анонс
18:17 ScienceDaily.comMore cancer cases among women with sleep apnea

Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows. No causal relationship is demonstrated, but the link between nocturnal hypoxia in women and higher cancer risk is still clear.

Скрыть анонс
15:53 Yahoo ScienceMoleculin Completes Enrollment in Early-Stage Cancer Study

Moleculin (MBRX) reaches enrollment target in a clinical study evaluating its p-STAT3 inhibitor, WP1220, as a treatment for cutaneous T-cell lymphoma, a form of skin cancer.

Скрыть анонс
15:39 FierceBiotech.comAstraZeneca drug heads to phase 2 in pancreatic cancer after small trial extends survival

University of Michigan researchers are reporting promising results from an early trial of AstraZeneca’s AZD1775, a drug that blocks an enzyme cancer cells need to repair their own DNA.

Скрыть анонс
13:20 FightAging.OrgSupport for LIfT Biosciences to Develop the LIFT Approach to a Universal Cancer Therapy

It is good to see that more of the promising technical approaches to aspects of aging, originally put forward by people in the SENS rejuvenation research network some years ago, are now making solid progress towards commercial implementation. The LIFT, or GIFT, approach to cancer therapy involves the transplantation of suitably aggressive leukocyte or granulocyte immune cells from a donor. At the time it was first demonstrated to be highly effective in mice, more than a decade ago, the underlying mechanisms were not well explored, and that always makes it hard to obtain further support from scientific funding institutions. This is despite the point that the approach has the potential to be a near universal cancer therapy, applicable to most or all forms of cancer, […]

Скрыть анонс
09:30 Nanowerk.comNanocapsule reaches cancer that has spread to central nervous system in mice

Cancer that has spread to the central nervous system is notoriously difficult to treat. Now, researchers have developed a drug delivery system that breaks through the blood-brain barrier in order to reach and treat cancer that has spread to the central nervous system.

Скрыть анонс
06:09 News-Medical.NetNew drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

Скрыть анонс
03:44 MedicalNewsToday.comMedical News Today: How might the keto diet help treat cancer?

Preclinical research in mice has examined the effect of ketogenic diet-induced glucose restriction on a certain type of cancer cell.

Скрыть анонс
03:44 MedicalNewsToday.comMedical News Today: Can itchy armpits be a sign of cancer?

Itchy armpits may occasionally be due to cancer, although there are many more likely causes. Infections and underlying skin conditions are some other reasons. Learn more here.

Скрыть анонс
02:27 ScienceMag.orgIn departure for NIH, Cancer Moonshot requires grantees to make papers immediately free

Open-access requirement diverges from usual U.S. government policy

Скрыть анонс
00:45 CancerNetwork.comDoes Evidence Support Screening for Pancreatic Cancer?

The U.S. Preventive Services Task Force released a new review of the benefits and harms of imaging-based screening for pancreatic cancer.

Скрыть анонс
14.08.2019
23:48 Phys.orgNanocapsule reaches cancer that has spread to central nervous system in mice

Cancer that has spread to the central nervous system is notoriously difficult to treat. Now, UCLA researchers have developed a drug delivery system that breaks through the blood-brain barrier in order to reach and treat cancer that has spread to the central nervous system.

Скрыть анонс
20:08 Yahoo ScienceVaccinex (VCNX) Attains Full Enrollment in Lung Cancer Study

Vaccinex (VCNX) completes enrollment in a phase Ib/II study of its pipeline candidate pepinemab in combination with Bavencio for treating advanced non-small cell lung cancer.

Скрыть анонс
18:52 ScienceDaily.comNew drug shows encouraging survival in pancreatic cancer

A phase 1 clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers. The trial looked at AZD1775, an inhibitor designed to block an enzyme called Wee1, which plays a role in DNA damage repair.

Скрыть анонс
17:56 ScienceDaily.comExercise associated with benefit to patients with advanced colorectal cancer

Patients with metastatic colorectal cancer who engaged in moderate exercise while undergoing chemotherapy tended to have delayed progression of their disease and fewer severe side effects from treatment, according to a new study.

Скрыть анонс
14:21 BBC HealthSimon Armitage pens poem on cancer pill

The Poet Laureate has his work micro-engraved on to a tablet to honour a new research centre.

Скрыть анонс
13:15 FightAging.OrgLike CD47, CD24 Also Acts as a "Don't Eat Me" Signal and is Abused by Cancer Cells

Cancer cells abuse signals used elsewhere in normal mammalian biochemistry to prevent immune cells from destroying other cells, such as CD47. Interfering in these "don't eat me" signals has produced significant gains in the development of effective cancer therapies that can target multiple types of cancer. Here, researchers describe a newly discovered "don't eat me" signal, CD24, that should allow this class of cancer therapy to be expanded to target cancers that have proved resilient to existing implementations. This and related lines of work that lead to more general anti-cancer platforms are one of the reasons why young people today should have little concern over cancer in their old age yet to come. It will be near entirely a controllable condition, treated efficiently with few […]

Скрыть анонс
11:57 ClinicalOncology.comHIV-Positive + Age = Higher Cancer Mortality

Older HIV patients with cancer fare far worse than HIV-negative patients.

Скрыть анонс
11:21 Reuters.com HealthAstraZeneca scores win in race to treat ovarian cancer

AstraZeneca has made further headway in the race with larger competitor GlaxoSmithKline's to use a promising new class of drugs to treat ovarian cancer.

Скрыть анонс
07:30 News-Medical.NetRoswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

Скрыть анонс
03:41 MedicalNewsToday.comMedical News Today: Pancreatic cancer cells spread by 'educating' the tumor environment

Why does pancreatic cancer spread? The answer may lie in a previously unknown set of molecules that help cancer cells shape the environment around tumors.

Скрыть анонс
00:33 NYT ScienceDrinking Bleach Won’t Cure Cancer or Anything Else, F.D.A. Says

Alarmed about misinformation online, the agency warned about bleach solutions that are being marketed as cures for autism, H.I.V./AIDS and cancer.

Скрыть анонс
00:11 NYT HealthDrinking Bleach Won’t Cure Cancer or Anything Else, F.D.A. Says

Alarmed about misinformation online, the agency warned about bleach solutions that are being marketed as cures for autism, H.I.V./AIDS and cancer.

Скрыть анонс
13.08.2019
22:10 ScienceDaily.comFlavonoid-rich diet protects against cancer and heart disease, study finds

Consuming flavonoid-rich items such as apples and tea protects against cancer and heart disease, particularly for smokers and heavy drinkers, according to new research.

Скрыть анонс
21:51 News-Medical.NetMice study suggests anti-cancer effect of ketogenic diet

It's well known that keeping blood glucose levels in check can help individuals avoid or manage diabetes, but new research led by biologists at The University of Texas at Dallas suggests that restricting blood glucose levels might also keep certain cancers at bay.

Скрыть анонс
20:23 CancerNetwork.comNew Diagnostic Tool for Thyroid Cancer

Naveed Saleh, MD, MS

Скрыть анонс
20:23 CancerNetwork.comNew Diagnostic Tool for Thyroid Cancer

Naveed Saleh, MD, MS

Скрыть анонс
19:23 Medscape.ComTestosterone May Be Safe After Prostate Cancer Treatment

Studies show similar survival in men who used testosterone after radical prostatectomy or radiation therapy compared with those who did not.

Скрыть анонс
18:41 CancerNetwork.comIs It Safe For Patients To Exercise During Treatment for Cancer?

Despite the toll chemotherapy can take on the body, experts say it's possible for athletes to exercise while undergoing treatment for cancer.

Скрыть анонс
18:06 Reuters.com HealthDeciphera shares skyrocket as cancer drug improves progression-free survival

Deciphera Pharmaceuticals Inc's shares more than doubled on Tuesday after the drugmaker said its late-stage study met the main goal of helping stomach cancer patients live longer without their disease worsening.

Скрыть анонс
17:10 Drugs.comHormone Therapy for Prostate Cancer Might Harm the Heart: Study

TUESDAY, Aug. 13, 2019 -- When men have both advanced prostate cancer and heart disease, treatment may pose a dilemma: Newer hormonal therapies that can slow the cancer down might also be risky for their hearts, a new study finds. Once prostate...

Скрыть анонс
16:45 News-Medical.NetConsuming flavonoid-rich items could protect against cancer and heart disease

Consuming flavonoid-rich items such as apples and tea protects against cancer and heart disease, particularly for smokers and heavy drinkers, according to new research from Edith Cowan University.

Скрыть анонс